Trial comparing treatments for Psychotic Disorders
Official title A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
ClinicalTrials.gov ID: NCT07836348
What this study is testing
- What it's testing
- This prospective study compares two models of inpatient psychiatric care for adults experiencing an acute psychotic episode of moderate to severe intensity that requires admission to a closed psychiatric setting. Participants may have a history of previous psychiatric hospitalizations.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Male participants aged 18 years or older.
- Acute psychiatric condition requiring admission to a closed psychiatric inpatient setting.
- Moderate-to-severe psychotic symptoms, defined as a six-item Positive and Negative Syndrome Scale (PANSS-6) total score greater than 14 and at least...
- Admission directly from the psychiatric emergency department.
- Stay of at least 5 days in the assigned study inpatient setting.
You likely can't join if
- Previous psychiatric hospitalization ending less than one month before the current admission.
- Hospitalization in the assigned study inpatient setting exceeding 180 days.
- Substance use as the primary clinical problem requiring hospitalization.
- Active organic medical condition requiring ongoing intensive medical monitoring.
- Intellectual developmental disability.
- Complex organic brain disorder, including dementia.
See the full eligibility criteria
- Male participants aged 18 years or older.
- Acute psychiatric condition requiring admission to a closed psychiatric inpatient setting.
- Moderate-to-severe psychotic symptoms, defined as a six-item Positive and Negative Syndrome Scale (PANSS-6) total score greater than 14 and at least one PANSS-6 item rated 5 or higher.
- Admission directly from the psychiatric emergency department.
- Stay of at least 5 days in the assigned study inpatient setting.
- Provision of informed consent to participate in the study.
- Voluntary or involuntary legal admission status.
- Previous psychiatric hospitalization ending less than one month before the current admission.
- Hospitalization in the assigned study inpatient setting exceeding 180 days.
- Substance use as the primary clinical problem requiring hospitalization.
- Active organic medical condition requiring ongoing intensive medical monitoring.
- Intellectual developmental disability.
- Complex organic brain disorder, including dementia.
The study team makes the final eligibility decision.
Where it's taking place
- Jerusalem, Jerusalem, Israel
Compensation & support
Compensation is likely for taking part in this study.
No amount is published here - ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jerusalem, Jerusalem, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.